Sana Biotechnology Inc (SANA)
3.74
+0.08
(+2.19%)
USD |
NASDAQ |
Nov 04, 16:00
3.69
-0.05
(-1.34%)
Pre-Market: 08:46
Sana Biotechnology Price: 3.74 for Nov. 4, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 04, 2024 | 3.66 | 3.81 | 3.53 | 3.74 | 657912.0 |
| Nov 01, 2024 | 3.54 | 3.67 | 3.47 | 3.66 | 1.320M |
| Oct 31, 2024 | 3.66 | 3.70 | 3.50 | 3.50 | 1.086M |
| Oct 30, 2024 | 3.75 | 3.94 | 3.66 | 3.66 | 1.020M |
| Oct 29, 2024 | 3.87 | 3.92 | 3.64 | 3.78 | 942010.0 |
| Oct 28, 2024 | 3.85 | 4.135 | 3.85 | 3.92 | 1.171M |
| Oct 25, 2024 | 3.85 | 3.89 | 3.728 | 3.76 | 701877.0 |
| Oct 24, 2024 | 3.80 | 3.82 | 3.695 | 3.81 | 832339.0 |
| Oct 23, 2024 | 3.93 | 3.96 | 3.69 | 3.79 | 1.062M |
| Oct 22, 2024 | 3.90 | 3.93 | 3.75 | 3.90 | 752582.0 |
| Oct 21, 2024 | 4.21 | 4.21 | 3.895 | 3.93 | 842018.0 |
| Oct 18, 2024 | 4.12 | 4.23 | 4.09 | 4.23 | 567289.0 |
| Oct 17, 2024 | 4.23 | 4.275 | 4.02 | 4.06 | 789479.0 |
| Oct 16, 2024 | 4.17 | 4.355 | 4.07 | 4.23 | 914933.0 |
| Oct 15, 2024 | 4.01 | 4.165 | 3.965 | 4.14 | 643665.0 |
| Oct 14, 2024 | 4.01 | 4.065 | 3.94 | 4.01 | 588003.0 |
| Oct 11, 2024 | 3.83 | 4.00 | 3.75 | 3.99 | 962494.0 |
| Oct 10, 2024 | 3.91 | 3.95 | 3.78 | 3.83 | 1.055M |
| Oct 09, 2024 | 4.02 | 4.15 | 3.92 | 3.99 | 824345.0 |
| Oct 08, 2024 | 4.19 | 4.30 | 4.06 | 4.08 | 1.001M |
| Oct 07, 2024 | 4.21 | 4.440 | 4.095 | 4.21 | 1.435M |
| Oct 04, 2024 | 4.36 | 4.40 | 4.22 | 4.23 | 846781.0 |
| Oct 03, 2024 | 4.29 | 4.355 | 4.21 | 4.25 | 1.301M |
| Oct 02, 2024 | 4.18 | 4.435 | 4.02 | 4.36 | 2.103M |
| Oct 01, 2024 | 4.16 | 4.26 | 4.01 | 4.24 | 1.499M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.80
Minimum
Oct 27 2023
43.50
Maximum
Feb 10 2021
10.08
Average
6.32
Median
Jun 28 2022
Price Benchmarks
| Foghorn Therapeutics Inc | 8.24 |
| Omega Therapeutics Inc | 1.055 |
| Moderna Inc | 53.54 |
| Summit Therapeutics Inc | 19.96 |
| Apellis Pharmaceuticals Inc | 28.52 |
Price Related Metrics
| Price to Book Value | 2.450 |
| Earnings Yield | -30.75% |
| Market Cap | 832.02M |